Index 26. Jahrgang, 2007 Inhalte Keywords

Schriftleitung:
D. Soyka
M. Spitzer
A. Ceballos-Baumann
H. Walter
Index 26. Jahrgang, 2007
Inhalte
Keywords
Schlüsselwörter
Autoren
http://www.nervenheilkunde-online.de
Inhalte – Nervenheilkunde 2007; 26 (1-12)
In eigener Sache
H. Walter
Neuroethik und Neurophilosophie ...................................................................................... 1
D. Soyka
Selbsthilfegruppen in der Nervenheilkunde..................................................................... 113
Zu diesem Heft
S. Evers
Innovative Therapieverfahren bei Kopfschmerzen............................................................... 3
P. Beschoner, A. Borchers
Aktuelles aus der psychiatrischen Forschung.................................................................. 115
H. Oertel
Das Kompetenznetz Parkinson ....................................................................................... 229
A. C. Ludolph
122. Wanderversammlung .............................................................................................. 333
A. Borchers
Psyche, Gehirn und Körper............................................................................................. 449
D. Soyka
Immunstörungen in der Psychiatrie und Neurologie ........................................................ 541
W. Maier
Das Kompetenznetz Demenzen...................................................................................... 641
D. Soyka
Innere Medizin und Nervensystem.................................................................................. 737
H. Walter
Neue Erkenntnisse in der molekularen Psychiatrie.......................................................... 841
D. Schmidt
Aktuelles Epilepsiemanagement ..................................................................................... 953
A. Ceballos-Baumann
3. Schwabinger Neuroseminar...................................................................................... 1073
Editorial
M. Spitzer
Gefühle Be-schreiben – Wissenschaft und Liebesbriefe ..................................................... 9
M. Spitzer
Geld macht einsam ........................................................................................................ 119
http://www.nervenheilkunde-online.de
II
Inhalte – Nervenheilkunde 2007; 26 (1-12)
M. Spitzer
Einkaufs-Zentren ........................................................................................................... 233
M. Spitzer
Das starke Gehirn des schwachen Geschlechts ............................................................. 337
M. Spitzer
Gleichheit ....................................................................................................................... 453
M. Spitzer
Moral und Mord im Namen Gottes? ............................................................................... 545
M. Spitzer
Zeige mir Deine Hand und ich sage Dir ... ...................................................................... 645
M. Spitzer
Wartezeiten ................................................................................................................... 743
M. Spitzer
Beobachtet werden ........................................................................................................ 847
M. Spitzer
Jahrzehnt des Geistes ................................................................................................... 957
M. Spitzer
Meditieren im Kopf ....................................................................................................... 1079
Arbeiten zum Schwerpunkt - Theme Articles
A. May, J. Vesper, S. Evers, G. Nikkhah
Operative und interventionelle Therapieverfahren beim Cluster-Kopfschmerz .................. 13
Interventional therapy in cluster headache
A. Antal, W. Paulus
Transkranielle Magnet- und Gleichstromstimulation bei Kopfschmerzen .......................... 22
Transcranial magnetic- and direct current stimulation as a treatment for headache
S. Evers
Migräne und offenes Foramen ovale – Was ist gesichert? ............................................... 27
Migraine and patent foramen ovale – What's firmed?
A. Gendolla, S. Evers
Alternative Heilverfahren bei Kopfschmerzen ................................................................... 32
Alternative therapies in headache
M. Marziniak
Neue Substanzen in der Akuttherapie der Migräne .......................................................... 35
New drugs in the acute treatment of migraine
P. Kropp, U. Niederberger
Neue verhaltenstherapeutische Verfahren in der Kopfschmerztherapie ............................ 43
New behavioraly oriented methods in head pain therapy
http://www.nervenheilkunde-online.de
III
Inhalte – Nervenheilkunde 2007; 26 (1-12)
P. Beschoner, M. Braun
Das Burnout-Syndrom bei Ärzten in Deutschland ........................................................... 125
Burnout in German physicians
N. Vasic, R. C. Wolf
Nichtreduktionistische Leib-Seele-Konzepte in der modernen Psychiatrie ...................... 134
An introduction to non-reductive body-mind concepts in modern psychiatry
B. Abler, N. Vasic
Rolle des zentralen dopaminergen Systems bei psychiatrischen Erkrankungen ............. 141
New insights concerning the role of the central dopaminergic system in psychiatric disorders
C. J. Bux, A. Rosenbohm, B. J. Connemann
Morbus Wilson als Differenzialdiagnose bei psychischen Störungen .............................. 150
Wilson's disease in patients with mental disorders
K. Eggert, H. Baas, G. Deuschl, R. Dodel, S. Franke, T. Gasser, T. Klockgether,
H. Reichmann, C. Trenkwalder, U. Wüllner, W. H. Oertel
Das Kompetenznetz Parkinson ...................................................................................... 239
G. Antony, K. Eggert, S. Franke, W. H. Oertel
Das Patientenregister .................................................................................................... 241
The patient register
U. Wüllner, S. Franke, G. Antony, K. Eggert
Genbank Parkinson-Krankheit Deutschland ................................................................... 246
Gene Bank Parkinson's Disease Germany
G. Deuschl, S. Franke
Tiefe Hirnstimulation bei fortgeschrittener Parkinson-Erkrankung ................................... 251
Deep brain stimulation in the therapy of advanced Parkinson’s disease
R. Dodel, A. Spottke
Ökonomische Analyse des Parkinson-Syndroms ........................................................... 256
Economic analysis of the Parkinson syndrome – Competence Network Parkinson
T. Walbert, J.-P. Reese, R. Dodel
Krankheitskosten neurologischer Erkrankungen in Deutschland .................................... 260
Cost-of-illness in neurological diseases in Germany
K. Eggert, R. Dodel, S. Franke, W. H. Oertel
Leitlinien für Diagnose und Therapie der Parkinson-Syndrome ...................................... 269
Guidelines for diagnosis and therapy of parkinsonian syndromes
A. Althaus, T. Kanis, A. Spottke, K. Eggert, I. Liepelt, D. Berg, F. Schneider, R. Dodel
Benchmarking in der Patientenversorgung ..................................................................... 277
Benchmarking in patient's care
E. Jüttler, T. Steiner
Hämostatische Therapie der intrazerebralen Blutung ..................................................... 343
Haemostatic therapy for intracerebral haemorrhage
http://www.nervenheilkunde-online.de
IV
Inhalte – Nervenheilkunde 2007; 26 (1-12)
M. Sitzer, F. Dvorak, C. Förch
Biomarker des Schlaganfalls .......................................................................................... 352
Biomarkers of stroke
J. Unger, N. Bergemann, M. Schwaninger
Hashimoto-Enzephalopathie – steroid-sensitive Enzephalopathie .................................. 357
Hashimoto encephalopathy – steroid-responsive encephalopathy
J. Dorst, P. Kuehnlein, A. D. Sperfeld, A. C. Ludolph
Therapieoptionen bei der Amyotrophen Lateralsklerose (ALS) ....................................... 362
Therapy options in amyotrophic lateral sclerosis (ALS)
A. Reif, A. Schmitt, S. Fritzen, K. P. Lesch
Adulte Neurogenese und Schizophrenie – gibt es einen Zusammenhang? .................... 368
Adult neurogenesis and schizophrenia: is there a link?
W. Maier
Durchbruch in der Ursachenforschung bei der Schizophrenie ........................................ 377
Breakthrough in the etiology of schizophrenia
F. Schlagenhauf, G. Juckel, J. Wrase, J. Gallinat, A. Heinz
Störung des Belohnungssystems bei schizophrenen Patienten und der Einfluss
typischer und atypischer Neuroleptika ............................................................................ 381
Dysfunction of the brain reward system in schizophrenic patients and the effect
of typical and atypical antipsychotics
H. N. Weiler
Hochschulpolitik Made in USA – Vorbild oder Warnung für Deutschland? ...................... 387
Higher education made in USA: should Germany follow or resist?
C. A. Bruenahl, P. C. Arck, B. F. Klapp, M. Linden
Immunologische Imbalancen bei Stress ......................................................................... 553
Cytokines and psychological stress
J. Dörr, F. Zipp
Guillain-Barré-Syndrom – Aktuelle Aspekte der Pathogenese,
Diagnostik und Therapie ................................................................................................ 560
Guillain-Barré-Syndrome: current aspects of pathogenesis, diagnosis, and therapy
A. Engelhardt
Immunvermittelte Polyneuropathien ............................................................................... 567
Immune-mediated polyneuropathies
R. Gold, W. Brück
Fortschritte in der Pathogeneseforschung der Multiplen Sklerose .................................. 572
Recent advances in pathogenesis of multiple sclerosis
P. Berlit
Vaskulitis und Nervensystem ......................................................................................... 578
Vasculitis and the nervous system
J. Dörr, F. Zipp
Myasthenia gravis – Aktuelle Aspekte der Pathogenese, Diagnostik und Therapie ........ 587
Myasthenia gravis: current aspects of pathogenesis, diagnosis, and therapy
http://www.nervenheilkunde-online.de
V
Inhalte – Nervenheilkunde 2007; 26 (1-12)
M. Stephan, K. Eger
Immunvermittelte Erkrankungen der neuromuskulären Übertragung .............................. 595
Immune-mediated disorders of the neuromuscular transmission
K. Schmidtke, M. Hüll
Neuropsychologische Untersuchung von Patienten bei Demenzverdacht ...................... 651
Neuropsychological examination of patients with suspected dementia
F. Jessen
Sind subjektive Gedächtnisstörungen ein Prodromalsyndrom der Demenz? .................. 659
Is subjective memory impairment a prodromal state of dementia?
O. Schulte-Herbrüggen, I. Heuser
Affektive und Verhaltensstörungen bei Demenz ............................................................. 663
Affective and behavioral disorders in dementia
H. Kaduszkiewicz, B. Wiese, H. van den Bussche
Kompetenz, Grundeinstellung und professionelles Handlungskonzept von
Hausärzten und Spezialisten in der Versorgung Demenzkranker ................................... 670
Competence, general attitude and professional approach in ambulatory care
of dementia patients
S. Külz, O. Rienhoff
Gesundheitsinformationen zu Demenzen ....................................................................... 679
Health information regarding dementia
S. Jansen
Fünf Jahre Alzheimer-Telefon der Deutschen Alzheimer Gesellschaft ........................... 685
Five years Alzheimer helpline of German Alzheimer Association
W. Dietrich, F. Erbguth
Neurologische Komplikationen bei Diabetes mellitus ...................................................... 747
Neurologic complications of diabetes mellitus
F. Erbguth, W. Dietrich
Aktuelle Aspekte der Rolle des Gehirns beim Diabetes mellitus ..................................... 759
Current aspects of the role of the brain in diabetes mellitus
N. Üçeyler, B. Sellhaus, C. Sommer, K. Reiners
Polyneuropathien bei Porphyrie ..................................................................................... 763
Porphyria induced neuropathy
M. Dieterich
Vitamin-B12-Mangel und funikuläre Myelose ................................................................... 769
Vitamin B12 deficiency and funicular myelosis
A. Straube, W. Hermann
Morbus Wilson ............................................................................................................... 774
Wilson's disease
R. H. van Schayck, M. Hurst
Das Wernicke-Korsakow-Syndrom ................................................................................. 781
The Wernicke-Korsakow syndrome
http://www.nervenheilkunde-online.de
VI
Inhalte – Nervenheilkunde 2007; 26 (1-12)
P. Berlit
Riesenzellarteriitis .......................................................................................................... 787
Giant cell arteritis
J. Wiltfang, M. Bibl, M. Maler, H.-W. Klafki, H. Esselmann, J. Kornhuber, P. Lewczuk
Neurochemische Frühdiagnostik und klinische Neuroproteomik
demenzieller Erkrankungen ............................................................................................ 853
Neurochemical early diagnostic and clinical neuroproteomik in dementia diseases
J. Wiltfang, M. Bibl, M. Maler, H.-W. Klafki, H. Esselmann, J. Kornhuber, P. Lewczuk
Neurochemische Demenzdiagnostik – Quo vadis? ........................................................ 861
Neurochemical diagnostic of dementia - quo vadis?
J. Alferink
Die Rolle des Immunsystems bei der Alzheimer-Demenz .............................................. 867
The immune response in Alzheimer’s Disease
W. Maier
Genetik affektiver Störungen .......................................................................................... 876
Genetics of affective disorders
M. Zink, A. Meyer-Lindenberg
Die molekulare Neurobiologie schizophrener Psychosen ............................................... 882
Molecular neurobiology of schizophrenia
R. Hünnerkopf, J. Thome
Moderne neuropsychiatrische Diagnostik ....................................................................... 891
Modern neuropsychiatric diagnostics
B. Schürmann, I. Rácz, A. Zimmer
Tierexperimentelle Untersuchungen zur Funktion des endogenen Opioidsystems
bei der Modulation von Suchtverhalten .......................................................................... 897
Animal experimental studies on the function of the endogenous opiod system
for the controlling of drug abuse
H. Stefan
Diagnose von Epilepsien – Was ist notwendig und was ist nicht sinnvoll? ...................... 965
Diagnosis of epilepsies: What is necessary to do and what is inadequate
D. Schmidt, G. Eckermann, U. Fuhr, G. Luef, B. J. Steinhoff, C. E. Elger
Arzneimittelinteraktionen bei der medikamentösen Epilepsietherapie
– Ein kritischer Überblick ................................................................................................ 969
Drug interactions and epilepsy treatment: A critical review
E. Trinka
Notfälle im Bereich der Epilepsien – Was tun und was lassen? ...................................... 981
Emergency in epilepsy: What must and must not be done?
H. Potschka
Mechanismen der Pharmakoresistenz ........................................................................... 993
Mechanisms of pharmacoresistance
C. Baumgartner
Neurostimulation zur Behandlung von Epilepsien – Eine kritische Bilanz ....................... 999
Neurostimulation in epilepsy treatment: A critical review
http://www.nervenheilkunde-online.de
VII
Inhalte – Nervenheilkunde 2007; 26 (1-12)
A. Schulze-Bonhage
Epilepsiechirurgie – Welche Patienten profitieren am meisten? .................................... 1006
Epilepsy surgery: Which patients gain most?
E. Wagner-Sonntag
Schlucktherapie bei neurologischen Erkrankungen ...................................................... 1083
Swallowing therapy in neurological diseases
K. Ziegler
Evidenzbasierte Physiotherapie bei Multipler Sklerose ................................................. 1088
Evidence based physiotherapy for multiple sclerosis
M. Paulig
Multiple Sklerose ......................................................................................................... 1095
Multiple Sclerosis
A. Ceballos-Baumann
Blasenstörungen bei Parkinson-Syndromen ................................................................. 1101
Urinary dysfunction in parkinsonism
J. Menne
Hypertonus – Therapie in der Praxis ............................................................................ 1111
Hypertension – practical hints regarding therapy
R. Schmid-Elsaesser
Die aneurysmatische Subarachnoidalblutung ............................................................... 1115
Aneurysmal subarachnoid hemorrhage
R. D. Rothoerl, F. Ringel, B. Meyer
Strategien zur Resektion von Gliomen in eloquenten Hirnarealen ................................ 1123
Strategies for resection of gliomas in eloquent areas of the brain
Original- und Übersichtsarbeiten - Original and Review
Articles
J. Pantel, J. Schröder
Die leichte kognitive Beeinträchtigung .............................................................................. 49
Mild cognitive impairment
D. Schmidt, B. Pohlmann-Eden, H. Stefan, C. E. Elger
Was tun, wenn das erste Medikament versagt? ............................................................... 61
What to do if the first treatment does not work?
F. Hohl-Radke, J. Staedt, G. Arentewicz
Erfahrungen mit Suizidalität in der stationären psychiatrischen Versorgung ..................... 67
Experience with suicidal behaviour in psychiatric hospital care
B. G. H. Schoser
Myotone Dystrophien – Phänotypen, Pathogenese, Diagnostik und Therapie .................. 74
Myotonic dystrophies – phenotypes, pathogenesis, diagnostics and therapy
http://www.nervenheilkunde-online.de
VIII
Inhalte – Nervenheilkunde 2007; 26 (1-12)
M. Keidel
Posttraumatischer Kopfschmerz ..................................................................................... 156
Posttraumatic headache
R. Wörz
Der Schmerz im Wechselspiel von Nozizeption und Bewusstsein .................................. 167
Widening pain: From nociception to consciousness
J. E. Bergk, M. Lang, R.-P. Gebhardt
Höhere Inanspruchnahme des therapeutischen Angebots auf spezialisierten
Depressionsstationen .................................................................................................... 173
Higher utilization of the therapeutic options on specialized wards for
depressive disorders
H.-C. Diener, V. Pfaffenrath
Wirksamkeit und Verträglichkeit von Frovatriptan in der Praxis ...................................... 180
Efficacy and tolerability of frovatriptan in clinical practice
A. Straube, A. May, P. Kropp, Z. Katsarava, G. Haag, C. Lampl, P. S. Sándor,
H.-C. Diener, S. Evers
Therapie primärer chronischer Kopfschmerzen: Chronische Migräne,
chronischer Kopfschmerz vom Spannungstyp und andere chronische
tägliche Kopfschmerzen ................................................................................................. 186
Therapy of primary headache: chronic migraine, chronic tension type headache
and other daily headaches
S. Bisler, E. Davids
Vorwissen über Psychopharmaka bei Patienten mit einer Störung
vom Borderline-Typus .................................................................................................... 281
Knowledge on psychopharmacological medication in patients with
a borderline personality disorder
M. Maschke, E. Busch, C. Nitsch, P. Dommes, C. Weimar, P. Berlit, A. Rogozinski,
H. Gerhard, V. Tenfelde, H. C. Diener
Dokumentation beim akuten Schlaganfall ...................................................................... 285
Documentation of acute stroke
A. Buchheim
Klinische Bindungsforschung – Methoden und Befunde ................................................. 291
Clinical attachment research: measures and results
K. E. Bühler, I. Eitel
Biografie und Persönlichkeit bei Depressiven, sonstigen psychiatrischen Patienten
und nicht-klinischen Probanden ..................................................................................... 301
Biography and personality of depressives, other psychiatric patients,
and non-clinical controls
U. M. Fietzek, B. Wiedenhöfer, L. Döderlein, S. Berweck
Zerebralparese – Übersicht und interdisziplinäre Therapie ............................................. 396
Cerebral palsy – overview and interdisciplinary therapy
http://www.nervenheilkunde-online.de
IX
Inhalte – Nervenheilkunde 2007; 26 (1-12)
H. Isermann
Geschichtliches zur Gründung von Anstalten für Menschen mit geistiger
Behinderung im deutschsprachigen Raum ..................................................................... 407
Historical facts on the foundation of institutions for mentally retarded people in the
German speaking area
K. Becker, C. Jennen-Steinmetz, M. H. Schmidt
Die Wender Utah Rating Scale ...................................................................................... 411
The WURS
L. Hermle, A. Bönsch, M. Ruchsow
Klinische Bedeutung der mit klassischen und atypischen Neuroleptika induzierten
Hyperprolaktinämie ........................................................................................................ 417
On conventional and atypical antipsychotics induced hyperprolactinaemia
F. Pedrosa Gil, M. Nickel
Religiöse und spirituelle Einstellungen in Bezug auf bindungstheoretische Aspekte bei
Somatoformen Störungen .............................................................................................. 459
Religious and spirituality attitudes regarding attachment theory aspects in
somatoform disorders
C. G. Schütz, J. Bludau
Tabakabhängigkeit und Tabakentwöhnung .................................................................... 465
Nicotine dependence and smoking cessation
M. Donix, T. Reuster
Apotemnophilie – Zur diagnostischen Klassifikation zwischen Paraphilie und
Körper-Integritäts-Identitätsstörung ................................................................................ 477
Apotemnophilia – diagnostic classification between paraphilia and body integrity
identity disorder
K.-L. Täschner
Cannabiskonsum und assoziierte psychische Störungen – Behandlungsstrategien ....... 481
Treatment strategies in cannabis consumers and patients with associated
psychic disorders
I. T. Calliess, W. Machleidt, M. Ziegenbein, H. Haltenhof
Migration und Suizidalität ............................................................................................... 487
Migration and suicidal behaviour
A. Conca, H. Hinterhuber, J. Di Pauli, A. Hausmann
Die transkranielle Magnetstimulation in der Psychiatrie: tatsächlich ein innovatives
Therapeutikum? ............................................................................................................. 492
The transcranial magnetic stimulation in psychiatry: Is it actually a new
therapeutic approach?
H. Spießl, A. Spießl, C. Cording, H. E. Klein
Intelligenzminderung – Teil 1: Einteilung, Häufigkeit, Ursachen und Diagnose ............... 603
Mental retardation – Part I: Classification, epidemiology, aetiology and diagnosis
H. Spießl, A. Spießl, C. Cording, H. E. Klein
Intelligenzminderung – Teil 2: Therapie und psychiatrische Versorgung ......................... 609
Mental retardation – Part II: Treatment and mental health care
http://www.nervenheilkunde-online.de
X
Inhalte – Nervenheilkunde 2007; 26 (1-12)
J. Westheide, K.-U. Kühn
Sexuelle Dysfunktion in der psychiatrischen Therapie .................................................... 690
Sexual dysfunction in psychiatric treatment
A. Büttner
Lebensqualität bei Insomnikern, Narkoleptikern und Schlafapnoikern ............................ 699
Quality of life in patients with insomnia, narcolepsy and obstructive sleep apnea
D. Schoepf, B. Konradt, H. Walter
Spezifische Psychotherapie der chronischen Depression mit dem Cognitive
Behavioral Analysis System of Psychotherapy ............................................................... 790
Specific psychotherapy of chronic depression with the Cognitive
Behavioral Analysis System of Psychotherapy
F. Petermann, S. Winkel
Selbstverletzendes Verhalten ......................................................................................... 805
Self-injurious behaviour
U. M. Fietzek, F. Schroeteler, K. Ziegler, A. Ceballos-Baumann
Gangstörungen .............................................................................................................. 903
Gait disorders
A. Hufnagel
Schnellaufdosierung von Valproinsäure bei Patienten mit Altersepilepsie ...................... 915
Rapid loading of Valproate in elderly patients with epilepsy
E. Kumbier, S. C. Herpertz
Induzierter Dermatozoenwahn (Folie à deux) – Ein Fallbericht ..................................... 1013
Induced delusion of parasitosis (Folie à deux): A case report
A. Büttner, R. Alnabary, K. H. Rühle
Gedächtnisprozesse bei obstruktivem Schlafapnoe-Syndrom vor und unter
CPAP-Therapie ............................................................................................................ 1018
Memory processes of obstructive sleep apnoea syndrome before and under
CPAP therapy
M. Zink
Kombinierte antipsychotische Therapie mit Clozapin und Aripiprazol ........................... 1029
Combined antipsychotic treatment involving clozapin and aripiprazol
A. Buchheim, U. Ziegenhain, A. Peter, H. von Wietersheim, A. Vicari, A. Kolb, U. Schulze
Unverarbeitete Verlusterfahrungen und Angststörungen .............................................. 1130
Unresolved experiences of loss and anxiety disorders
M. Bormuth
Psychiatrie als Passion ................................................................................................ 1136
Passion psychiatry
http://www.nervenheilkunde-online.de
XI
Inhalte – Nervenheilkunde 2007; 26 (1-12)
Der besondere Fall
M. Bös, J. Bauer
Wirbelkörperkompressionsfraktur durch epileptische Anfälle .......................................... 421
Compression fractures of the vertebrae during epileptic seizures
Geist und Gehirn – Mind & Brain
M. Spitzer
Unbewusste Logik – Mit Schlafmittel und ohne Hippocampus besser schließen ............... 79
M. Spitzer
Normierung im Gehirn .................................................................................................... 200
M. Spitzer
Heidegger und das Frühstück kalifornischer Raben ....................................................... 309
M. Spitzer
Logisch denkende Fische und lehrende Erdmännchen ................................................. 424
M. Spitzer
Entscheidungsfindung beim Blutegel .............................................................................. 501
M. Spitzer
Modelle für die Forschung .............................................................................................. 615
M. Spitzer
Vom Geld zur Aktion – Unbewusste Motivation im Scanner ........................................... 710
M. Spitzer
Die Qual der Wahl .......................................................................................................... 810
M. Spitzer
Aktives Vergessen ......................................................................................................... 920
M. Spitzer
Achtung: Baby-TV ........................................................................................................ 1036
M. Spitzer
Geschlecht und Gehirn – Frauen wissen durchaus, wo es langgeht ............................. 1144
http://www.nervenheilkunde-online.de
XII
Inhalte – Nervenheilkunde 2007; 26 (1-12)
Neuroethik & Neurophilosophie
S. Schleim, H. Walter
Cognitive Enhancement – Fakten und Mythen ................................................................. 83
H. Walter, S. Schleim
Vom Sein des Sollens .................................................................................................... 312
S. Schleim, H. Walter
Gedankenlesen mit dem Hirnscanner? .......................................................................... 505
T. Galert, S. Schleim
Eingriff ins Gehirn oder Angriff auf die psychische Integrität? ......................................... 618
S. Schleim, T. M. Spranger, H. Walter
Von der Neuroethik zum Neurorecht? ............................................................................ 813
T. Schläpfer
Neuromodulatorische Interventionen zur Therapie psychiatrischer Erkrankungen .......... 923
S. Schleim, T. Spranger, H. Urbach, H. Walter
Zufallsfunde in der bildgebenden Hirnforschung – Empirische, rechtliche und
ethische Aspekte ......................................................................................................... 1041
R. M. Cichy
Transkranielle Hirnstimulation – Kausalität zwischen Gehirn und Geist? ...................... 1148
http://www.nervenheilkunde-online.de
XIII
Schlüsselworte – Nervenheilkunde 2007; 26 (1-12)
5HT1B/1D-Rezeptoragonisten........180
ADHS ..................................................411
Adulte Neurogenese.........................368
Aggression..........................................663
Akkulturative Stresstheorie..............487
Akute hepatische Porphyrien ..........763
Akuttherapie......................................... 35
Alkohol.................................................897
Alzheimer............................................685
Alzheimer-Demenz
.....................49, 670, 853, 861, 867
Amerikanische Hochschulen ...........387
Amyloidpeptid............................853, 861
Amyotrophe Lateralsklerose............362
Anfallsfreiheit....................................1006
Angststörungen..................................291
Anticholinergika...............................1101
Antidementiva ....................................663
Antidepressiva ...................................690
Antiepileptika..................969, 993, 1006
Antigenpräsentierende Zellen.........867
Antikonvulsive Therapie ...................915
Antipsychotika....................................381
Anwendungsbeobachtung...............180
Apotemnophilie..................................477
Aripiprazol.........................................1029
Arteriitis cranialis ...............................787
Arzneimittelinteraktionen..................969
Ärzte ....................................................670
Ärztegesundheit.................................125
ATP7B .................................................774
Atypische Neuroleptika.....................417
Augmentation...................................1029
Autoantikörper....................................587
Axonal .................................................560
Azetylcholinrezeptor..........................587
Behandlungsphasen.........................790
Behandlungsprogramme..................481
Behandlungsstrategien.....................790
Belastungsstörung.............................553
Belohnungssystem ...................141, 381
Benchmarking....................................277
Beschleunigungsverletzung der
Halswirbelsäule..........................156
Beta-Amyloidpeptid..................853, 861
Bewegungsstörung...........................396
Bewusstsein .......................................167
Bewusstseinsdefinitionen.................167
Bindungsmethodik.............................291
Bindungstheorie.................................459
Biofeedback.......................................... 43
Biografie..............................................301
Bioichthyotherapie.............................492
Biomarker................ 352, 853, 861, 891
Biomaterialbank.................................246
Bipolare Störungen...........................876
Blasenstörungen..............................1101
Borderline-Persönlichkeitsstörung
.............................................281, 291
Botulinumtoxin .................................1101
Burnout................................................125
Calcitonin gene-related Peptid...........35
Cannabis ............................................ 897
Cannabis -assoziierte Störungen.... 481
Cannabis -induzierte Psychosen..... 481
Chronische Migräne.......................... 186
Clozapin............................................1029
Cobalamin .......................................... 769
Coeruloplasmin.................................. 150
Commotio cerebri.............................. 156
Datenschutz.............................. 241, 246
Demenz
........651, 659, 663, 670, 679, 685,
747, 759
Demyelinisierend............................... 560
Depression
173. 277, 291, 301, 663, 747, 759
Dermatozoenwahn..........................1013
Desensibilisierung................................43
Deutsche Hochschulen .................... 387
Deutschland....................................... 125
Diabetes mellitus ...................... 747, 759
Diagnose........................ 269, 352, 1095
Diagnostik... 651, 763, 805, 1083, 1115
Dispositionsgene............................... 377
DM1 ........................................................74
DM2 ........................................................74
Dokumentation .................................. 285
Dopamin............................................. 141
Dopaminergika................................1101
D-Penicillamin.................................... 774
DSM-IV ............................................... 603
Dualismus........................................... 134
ECRF .................................................. 241
Effekt der gelernten Hilflosigkeit..... 790
Einstellung.......................................... 670
Ekbom -Syndrom..............................1013
Elektrizität........................................... 492
Elektrokrampftherapie ...................... 492
Eloquente Hirnareale......................1123
Endovaskuläre Therapie................1115
Entscheidungsstrukturen................. 387
Enzephalomyeloneuropathie........... 769
Enzephalopathie................................ 578
Epilepsie...................915, 965, 993, 999
Epilepsiechirurgie............................1006
Epilepsiesyndrome............................ 965
Epilepsietherapie............................... 969
Epileptische Anfälle.......................... 965
Epileptischer Notfall.......................... 915
Episodischer und
chronischer Kopfschmerz vom
Spannungstyp............................ 186
Erektile Dysfunktion.......................... 690
Erwachsenenalter............................. 411
Evidenz............................................... 260
Evidenz-basierte Kriterien...................32
Evidenzbasierte Therapie..............1083
Gangstörung.......................................903
GBS......................................................567
Gedächtnisprozesse....................... 1018
Gefäßwandentzündung....................578
Gehirn..................................................759
Geist.....................................................134
Geistige Behinderung........................407
Gelegenheitsanfälle...........................965
Gelerntes und regelgeleitetes
Verhalten.....................................790
Genbank..............................................246
Genetik................................................876
Genetische Tiermodelle....................897
Genomics ............................................891
GEPARD .............................................246
Gesundheitsinformationen...............679
Gesundheitsökonomie ......................256
Gesundheitssystem ...........................260
Gleichgewichtstraining................... 1088
Gleichstromstimulation........................22
Gliome.............................................. 1123
Gründung von Heil- und
Pflegeanstalten..........................407
Guillain-Barré-Syndrom ....................560
H1069Q-Mutation ..............................774
Hämorrhagischer Schlaganfall........352
Hashimoto-Enzephalopathie............357
Hausärztliche Versorgung................670
Hemicrania continua..........................186
Hippocampus......................................659
Hirninfarkt............................................747
Hochschulautonomie.........................387
Hochschulfinanzierung......................387
HWS-Trauma......................................156
Hyperkinetische Störung..................411
Hyperprolaktinämie............................417
Hypertonie........................................ 1111
Hypovitaminose..................................769
ICD-10 .................................................603
IL-10/12-Ratio.....................................553
Immunantwort.....................................867
Immuntherapie...................................572
Induzierter Wahn............................. 1013
Inflammatorisch..................................560
Infliximab.............................................787
Intelligenzminderung................603, 609
Intentionstremor.............................. 1088
Internet................................................679
Intrakranielles Hämatom...................156
Intraoperatives Monitoring............. 1123
Intravenöse Antiepileptika ................981
Intrazerebrale Blutung.......................343
Intrinsic Faktor-Mangel.....................769
Ischämischer Schlaganfall................352
FMRT .................................................. 381
Folie-à-deux.....................................1013
Frovatriptan........................................ 180
Funikuläre Myelose........................... 769
http://www.nervenheilkunde-online.de
XIV
Schlüsselworte – Nervenheilkunde 2007; 26 (1-12)
Kandidatengene................................368
Katheterverschluss.............................. 27
Kausale Therapie..............................362
Kinder..................................................396
Kliniksuizid............................................ 67
Klinische Bindungsforschung..........291
Klinische Neurochemie............853, 861
Klinische Praxis .................................805
Klinische Studien...............................343
Kombination.....................................1029
Kombinationstherapie.......................969
Kompetenz.........................................670
Kontrollierte Doppelblindstudie.......935
Konversion zur Demenz..................... 49
Kopfschmerz..................................22, 43
Kopfschmerz bei
Medikamentenübergebrauch...186
Kopfschmerz vom Spannungstyp ...156
Körper..................................................134
Körper-Identitäts-Integritätsstörung477
Korsakow-Syndrom...........................781
Kortikosteroide...................................578
Kosten .................................................260
Krafttraining......................................1088
Kraniotomie........................................156
Krankheitskosten...............................256
Krankheitskostenstudie....................260
Krankheitsmodifizierende
Medikamente............................1095
Kulturwandel.......................................487
Kupfer.........................................150, 774
Lambert-Eaton-Syndrom..................596
Laufbandtraining..............................1088
Lebensereignisse..............................301
Lebensqualität.................. 251, 256, 699
Leichte kognitive Beeinträchtigung... 49
Leitlinien..............................................269
Liquor zerebrospinalis..............853, 861
Lokomotion.........................................903
Lymphozyten......................................572
M. Parkinson....................................1083
M. Wilson............................................150
Magnetismus ......................................492
Magnetresonanztomografie.............882
Massenspektrometrie.......................891
Materialismus .....................................134
Migräne............................. 22, 27, 32, 35
Migränetherapie.................................180
Migration.............................................487
Mikrogliazellen ...................................867
Molekulare Pathologie......................572
Mononeuritis multiplex......................578
Morbus Parkinson.............................251
MRT.....................................................787
Multiple Sklerose....................572, 1095
MuSK-Antikörper...............................596
Muskeldehnungen...........................1088
Muskelrelaxantien.............................935
Myasthenia gravis ....................587, 596
Myotone Dystrophien.......................... 74
Nächtliche Schlafqualität.................. 699
Naturheilkundliche Therapie...............32
NCPAP..............................................1018
Nervensystem.................................... 747
Neu aufgetretener Kopfschmerz..... 186
Neuritis................................................ 567
Neurobiologie............................ 291, 882
Neurochirurgische Therapie..........1115
Neurogenetik...................................... 882
Neuroleptika.............................. 663, 690
Neurologie.......................................... 260
Neuromyotonie .................................. 596
Neuronale Stammzellen................... 368
Neuronavigation ..............................1123
Neuropathie........................................ 763
Neuroprotektion................................. 572
Neuropsychiatrisches Syndrom ...... 357
Neuropsychologie............................. 651
Neurostimulation............................... 999
Nicht konvulsiver Status
epilepticus .................................. 981
Nicht-epileptische Anfälle................ 965
Nikotin................................................. 897
Nikotinersatztherapie........................ 465
Nozizeption ........................................ 167
Nucleus accumbens ......................... 381
Obstruktives
Schlafapnoe-Syndrom............1018
Offenes Foramen ovale.......................27
Opiate.................................................. 897
Outcome...........................................1006
Paraphilie............................................ 477
Paraproteinämien.............................. 567
Parkinson................................... 256, 903
Parkinson-Krankheit......................... 277
Parkinson-Syndrom ............... 269, 1101
Pathogenese...................................... 882
Pathophysiologie............................... 377
Patientenregister............................... 241
PDQ-39............................................... 251
Perniziöse Anämie............................ 769
Persönlichkeit.................................... 301
Pflegende Angehörige...................... 685
Pharmakoresistenz........................... 993
Philosophie des Geistes .................. 134
Physiotherapie.................................1088
Polyneuropathie...............560, 567, 747
Porphyrie............................................ 763
Postmortem -Studie........................... 368
Posttraumatischer Kopfschmerz..... 156
Prädiktoren................................ 67, 1006
Prä-emptive Therapie..........................43
Prästationäre Versorgung................ 285
Primärsozialisation............................ 301
Prognose............................................ 352
Prophylaxe ............................................32
Proteomics ......................................... 891
Prozessqualität.................................. 173
Psychiatrie................173, 603, 609, 891
Psychiatrie- und
Medizingeschichte .................... 492
Psychiatrie und Pädagogik.............. 407
Psychiatrische Erkrankungen.......... 141
Psychiatrische Methoden................. 134
Psychiatrische Symptome............... 150
http://www.nervenheilkunde-online.de
Psychische Erkrankungen................368
Psychische Störungen .............603, 609
Psychischer Stress............................553
Psychoedukation................................281
Psychopharmakotherapie.................281
Psychosoziale Faktoren................. 1006
Qualifikation........................................670
Qualitätsentwicklung.........................679
Qualitätsmessung..............................277
Randomisierte ....................................935
RDE......................................................241
Recurrence.........................................180
Religiosität..........................................459
Repeat-Erkrankung.............................74
Riesenzellarteriitis..............................787
Risperidon...........................................417
RTMS ...................................................999
Schädel-Hirn-Trauma........................156
Schilling-Test......................................769
Schizophrenie
................368, 377, 381, 882, 1029
Schlaganfall .............................285, 1083
Schlaganfallregister...........................285
Schluckstörungen ........................... 1083
Schmerz.......................................22, 167
Schmerzdefinitionen..........................167
Schnellaufdosierung..........................915
Sekundärprävention ............................49
Selbstverletzendes Verhalten..........805
Serotonin......................................35, 141
Serummarker......................................352
Sexuelle Funktionsstörungen..........690
Somatoforme Störungen..................459
Spastizität............................................396
Spastizität/Spastik .............................935
Spezifische Psychotherapie der
chronischen Depression...........790
Stationäre Behandlung.....................173
Status epilepticus...............................981
Steroid-sensitive Enzephalopathie.357
Striatum...............................................141
Stürze ..................................................903
Subarachnoidalblutung.................. 1115
Subjektive Gedächtnisstörungen....659
Sucht....................................................897
Suizidales Verhalten............................67
Suizidalität...........................................487
Symptomatische Therapie................362
Synapse..............................................587
XV
Schlüsselworte – Nervenheilkunde 2007; 26 (1-12)
Tabakabhängigkeit............................465
Tabakentwöhnung.............................465
Tagesbefindlichkeit...........................699
Takayasu-Arteriitis.............................787
Tau-Protein................................853, 861
Telefon-Beratung...............................685
Therapie
....... 74, 269, 343, 805, 1095, 1111
Therapieleitlinien...............................186
Therapieziele......................................790
Thiamin...............................................781
Tiefe Hirnstimulation .........................251
Tolperison...........................................935
Transkranielle Magnetstimulation
...................................... 22, 492, 999
Trien.....................................................774
Triptane...............................................180
T-Zellen...............................................867
Unerwünschte Wirkungen................969
Unipolare Depression .......................876
Unterschiedliche Stationskonzepte 173
Valproat intravenös ...........................915
Vaskulitis....................................567, 578
Verhaltensstörungen.........................663
Verhaltenstherapie.............................. 43
Versorgung.........................................679
Verträglichkeit....................................180
Vitamin B1 ...........................................781
Vitamin B12..........................................769
VNS .....................................................999
Web-based Data-Entry.....................241
Wender Utah Rating Scale..............411
Wernicke-Enzephalopathie..............781
Wettbewerb........................................387
Wirkeintritt...........................................180
Wirksamkeit........................................180
Wirkungsverlust.................................969
Wissenschaftssysteme
im Vergleich................................387
Zerebrales Aneurysma...................1115
Zerebralparese...................................396
Ziele...................................................1006
Zink ......................................................774
Zytokine...............................................553
http://www.nervenheilkunde-online.de
XVI
Keywords – Nervenheilkunde 2007; 26 (1-12)
5HT1B/1D-receptor agonist.............180
Acetylcholine receptor......................587
Acute hepatic porphyrias..................763
Acute treatment................................... 35
Adaptive immune response.............867
Addiction.............................................897
ADHD ..................................................411
Adult Attachment Interview............1130
Adult neurogenesis ...........................368
Adulthood............................................411
Adverse effects..................................969
Aggression..........................................663
Aims...................................................1006
Alcohol.................................................897
Alzheimer’s dementia......................... 49
Alzheimer’s disease........ 670, 685, 867
Alzheimer's Dementia..............853, 861
American universities........................387
Amyloid ......................................853, 861
Amyotrophic lateral sclerosis...........362
Anticholinergics................................1101
Anticonvulsive therapy......................915
Antidementia drugs ...........................663
Antidepressants .................................690
Antiepileptic drugs ... 61, 969,993, 1006
Antigen-presenting cells ...................867
Antipsychotics...........................381, 690
Anxiety disorders ....................291, 1130
Apotemnophilia..................................477
Aripiprazole.......................................1029
Assessment........................................805
Attachment measures.......................291
Attachment story completion task.1130
Attachment theory.............................459
Attitudes..............................................670
Atypical antipsychotics .....................417
Augmentation...................................1029
Autoantibodies ...................................587
Autonomy............................................387
Autosomal recessive disease..........774
Axonal .................................................560
Balancetraining................................1088
Behavior therapy................................. 43
Behavioral and psychological
symptoms (BPSD).....................663
Benchmarking....................................277
Beta-amyloid peptides .............853, 861
Biofeedback.......................................... 43
Biography............................................301
Bioichthyotherapy..............................492
Biomarker................ 352, 853, 861, 891
Biomaterial bank................................246
Bipolar disorders................................876
Blood serum marker..........................352
Body.....................................................134
Body integrity identity disorder........477
Borderline Personality
Disorder..............................281, 291
Botulinum toxin ................................1101
Brain....................................................759
Burnout................................................125
Calcitonin gene-related peptide ........ 35
Candidate genes ...............................368
Cannabis ............................................ 897
Cannabis associated disorders....... 481
Cannabis induced psychosis........... 481
Caregiver............................................ 685
Catheter closure...................................27
Causal therapy.................................. 362
Cerebral aneurysm .........................1115
Cerebral palsy.................................... 396
Cerebrospinal fluid................... 853, 861
Ceruloplasmin.................................... 150
Change of culture.............................. 487
Children.............................................. 396
Chronic migraine............................... 186
Clinical attachment research........... 291
Clinical neurochemistry........... 853, 861
Clinical practice................................. 805
Clinical trials ....................................... 343
Clozapine..........................................1029
Cluster headache.................................13
Cobalamin .......................................... 769
Cognitive Behavioural Analysis
System of Psychotherapy........ 790
Combination.....................................1029
Combination therapy........................ 969
Competence....................................... 670
Competition........................................ 387
Compression fractures ..................... 421
Conditioned and rigidly ruled
governed behaviour.................. 790
Consciousness .................................. 167
Controlled........................................... 935
Conversion to dementia......................49
Copper................................................ 774
Copper metabolism........................... 150
Corticosteroids................................... 578
Cost..................................................... 260
Cost-of-illness........................... 256, 260
Cranial arteritis .................................. 787
Craniotomy......................................... 156
Cytokines............................................ 553
Data safety................................ 241, 246
Decision-making structures ............. 387
Deep brain stimulation................13, 251
Definitions of consciousness........... 167
Delusional parasitosis ....................1013
Dementia
........651, 659, 663, 670, 679, 685,
747, 759
Demyelinating.................................... 560
Depression
173, 277, 291, 301, 663, 747, 759
Desensitization.....................................43
Diabetes mellitus ...................... 747, 759
Diagnosis...... 269, 352, 763, 965, 1095
Diagnostic.....................651, 1083, 1115
Different hospital settings ................ 173
Direct current stimulation....................22
Disease modifying drugs................1095
Disposition genes.............................. 377
DM1 ........................................................74
DM2 ........................................................74
Documentation.................................. 285
Dopamine........................................... 141
Dopaminergics.................................1101
Double-blind clinical trial .................. 935
http://www.nervenheilkunde-online.de
Drug interactions................................969
DSM-IV................................................603
Dualism................................................134
ECRF ...................................................241
EEG......................................................965
Efficacy................................................180
Ekbom syndrome............................ 1013
Electricity.............................................492
Electroconvulsive therapy................492
Eloquent area.................................. 1123
Encephalomyeloneuropathy............769
Encephalopathy.................................578
Endovascular therapy.................... 1115
Epilepsy.............................915, 993, 999
Epilepsy surgery............................. 1006
Epilepsy treatment......................61, 969
Epileptic emergency..........................915
Epileptic seizure........................421, 965
Episodic and chronic tension type
headache....................................186
Erectile dysfunction...........................690
Evidence based criteria......................32
Evidence-based.................................260
Evidence-based therapy................ 1083
Falls......................................................903
FMRT...................................................381
Folie-à-deux..................................... 1013
Foundation of institutions and homes
for mentally retarded people ....407
Frovatriptan.........................................180
Funicular myelosis .............................769
Gabapentin ...........................................61
Gadolinium -enhanced MRI ..............787
Gait disorder.......................................903
GBS......................................................567
Gene bank ..........................................246
Genetic animal models .....................897
Genetics ..............................................876
Genomics ............................................891
GEPARD .............................................246
German universities ..........................387
Germany..............................................125
Giant cell arteritis ...............................787
Glioma.............................................. 1123
Guideline....................................186, 269
Guillain-Barré-Syndrom ....................560
XVII
Keywords – Nervenheilkunde 2007; 26 (1-12)
Hans Heimann .................................1136
Hashimoto´s encephalopathy..........357
Head injury.........................................156
Headache.......................................22, 43
Health..................................................125
Health Care........................................679
Health economics ..............................256
Health Information.............................679
Healthcare system.............................260
Hemicrania continua .........................186
Hemorrhagic stroke...........................352
Herbal remedies .................................. 32
Higher education financing..............387
Hippocampus .....................................659
History of psychiatry and medicine.492
Hyperkinetic disorder........................411
Hyperprolactinemia ...........................417
Hypertension....................................1111
ICD-10.................................................603
IL-10/12-Ratio....................................553
Immunotherapy..................................572
Induced delusion.............................1013
Inflammatory.......................................560
Infliximab.............................................787
Initial epilepsy treatment..................... 61
In-patient suicide................................. 67
Inpatient treatment............................173
Intentionstremor...............................1088
International comparisons ................387
Internet................................................679
Interventional........................................ 13
Intracerebral haemorrhage..............343
Intracranial haematoma....................156
Intraoperative monitoring...............1123
Intravenous antiepileptic drugs .......981
Intravenous valproate .......................915
Intrinsic factor deficiency..................769
Ischemic stroke..................................352
Korsakow’s syndrome......................781
Lambert-Eaton-syndrome................596
Lamotrigine........................................... 61
Leadership in higher education.......387
Life-events..........................................301
Locomotion.........................................903
Loss of effect......................................969
Lymphocytes......................................572
Magnetic resonance tomography...882
Magnetism..........................................492
Mass spectrometry............................891
Materialism .........................................134
Medication overuse headache ........186
Mental disorders .......................150, 603
Mental retardation........... 407, 603, 609
Microglia..............................................867
Migraine............................ 22, 27, 32, 35
Migraine-therapy................................180
Migration.............................................487
Mild Cognitive Impairment................. 49
Mild traumatic brain injury................156
Mind.....................................................134
Molecular pathology..........................572
Movement disorder...........................396
MRI 965
Multidimensional psychiatry. .........1136
Multiple sclerosis .................... 572, 1095
Multiplex mononeuritis...................... 578
Muscle relaxants ............................... 935
Muscle stretching ............................1088
MuSK-antibodies ............................... 596
Myasthenia gravis.................... 587, 596
Myotonic dystrophy..............................74
Neck trauma....................................... 156
Negative copper balance................. 774
Nervous system................................. 747
Neural stem cells............................... 368
Neuritis................................................ 567
Neurobiology............................. 291, 882
Neurogenetics.................................... 882
Neuroleptics ....................................... 663
Neurology........................................... 260
Neuromyotonia .................................. 596
Neuronavigation ..............................1123
Neuropathy......................................... 763
Neuroprotection................................. 572
Neuropsychiatric syndrome............. 357
Neuropsychology.............................. 651
Neurostimulation............................... 999
Neurosurgical therapy....................1115
New daily persisting headache....... 186
Nicotine............................................... 897
Nicotine dependence........................ 465
Nicotine replacement........................ 465
Nociception........................................ 167
Non-compliance................................ 421
Non-convulsive Status epilepticus . 981
Non-epileptic attacks ........................ 965
Nucleus accumbens ......................... 381
Onset of action.................................. 180
Opioids................................................ 897
Outcome...........................................1006
Oxcarbazepine .....................................61
Pain ...............................................22, 167
Pain definitions .................................. 167
Paraphilia............................................ 477
Paraproteinemia................................ 567
Parkinson............................................ 256
Parkinson’s disease....251, 1083, 1101
Parkinsonian syndromes.................. 269
Parkinsonism ..................................... 903
Patent foramen ovale..........................27
Pathogenesis ..................................... 882
Pathography.....................................1136
Pathophysiology................................ 377
Patient register.................................. 241
PD ..................................................... 277
PDQ-39............................................... 251
Personality.......................................... 301
Pharmacoresistance......................... 993
Philosophy of mind............................ 134
Physician ............................................ 125
Physicians .......................................... 670
Physiotherapy..................................1088
Polyneuropathy.................560, 567, 747
Porphyria............................................ 763
Post mortem findings........................ 368
http://www.nervenheilkunde-online.de
Posttraumatic headache...................156
Predictors ...................................67, 1006
Pre-emptive treatment........................43
Pre-hospital care................................285
Prescription survey............................180
Primary care .......................................670
Primary socialisation.........................301
Process quality...................................173
Prognosis ............................................352
Prophylaxis ...........................................32
Proteomics ..........................................891
Psychiatric disorders .........................141
Psychiatric disorders .........................368
Psychiatric methods ..........................134
Psychiatric pharmacotherapy..........281
Psychiatry.................173, 603, 609, 891
Psychiatry and pedagogics ..............407
Psychoeducation................................281
Psychological stress..........................553
Psychopathology............................. 1136
Psychosocial factors....................... 1006
Qualification........................................670
Quality Development.........................679
Quality measurement........................277
Quality of life .....................251, 256, 699
Randomised........................................935
Rapid titration.....................................915
RDE system........................................241
Recommendations...............................61
Recurrence.........................................180
Religiosity............................................459
Repeat disorder....................................74
Resistance training......................... 1088
Reward system ..................................381
Reward-system ..................................141
Risperidone.........................................417
RTMS ...................................................999
Schilling test........................................769
Schizophrenia368, 377, 381, 882, 1029
Secondary prevention.........................49
Seizure freedom.............................. 1006
Self-injurious behaviour....................805
Serotonin...............................................35
Serotonine...........................................141
Sexual dysfunctions ..........................690
Sleep quality.......................................699
Smoking cessation............................465
Somatoform disorders.......................459
Spasticity....................................396, 935
Specific psychotherapy for chronic
depression..................................790
Status epilepticus...............................981
Steroid responsive encephalopathy
associated with autoimmune
thyroiditis (SREAT)....................357
Steroid responsive encephalopathy
associated with Hashimoto´s
thyroiditis (SREHT)....................357
Stress dysfunction.............................553
Striatum...............................................141
Stroke ..............................285, 747, 1083
Stroke registry....................................285
Subarachnoid hemorrhage............ 1115
XVIII
Keywords – Nervenheilkunde 2007; 26 (1-12)
Subjective memory impairment.......659
Suicidal behaviour...................... 67, 487
Swallowing disorders ......................1083
Symptomatic therapy........................362
Synapse..............................................587
Takayasu arteritis ..............................787
Tau .............................................853, 861
T-cells ..................................................867
Telephone counselling......................685
Tension-type headache....................156
The learned helplessness effect.....790
Theory of acculturative stress .........487
Therapy 13, 269, 343, 805, 1095, 1111
Thiamine .............................................781
Tolerability..........................................180
Tolperisone.........................................935
Topiramate ........................................... 61
Transcranial magnetic
stim ulation................... 22, 492, 999
Transdisciplinary methodology......1136
Treadmill training.............................1088
Treatment............................................. 74
Treatment goals.................................790
Treatment phases .............................790
Treatment programs .........................481
Treatment strategies .........................790
Trigemino-autonomic headache....... 13
Unipolar depression..........................876
Unresolved loss ...............................1130
Urinary symptoms ...........................1101
Vasculitis....................................567, 578
Vessel inflammation..........................578
Vitamin B1..........................................781
Vitamin B12........................................769
Vitamin deficiency.............................769
VNS .....................................................999
Web-based data-entry......................241
Wellbeing during the day..................699
Wender Utah Rating Scale..............411
Wernicke’s encephalopathy.............781
Whiplash injury...................................156
Wilson's Disease...............................150
http://www.nervenheilkunde-online.de
XIX
Autoren – Nervenheilkunde 2007; 26 (1-12)
Abler, B. ..............................................141
Alferink, J. ...........................................867
Alnabary, R.......................................1018
Althaus, A. ..........................................277
Antal, A. ................................................. 22
Antony, G...................................241, 246
Arck, P.C.............................................553
Arentewicz, G....................................... 67
Baas, H...............................................239
Bauer, J...............................................421
Baumgartner, C.................................999
Becker, K. ...........................................411
Berg, D................................................277
Bergemann, N....................................357
Bergk, J.E. ..........................................173
Berlit, P.............................. 285, 578, 787
Berweck, S. ........................................396
Beschoner, P.............................115, 125
Bibl, M. .......................................853, 861
Bisler, S...............................................281
Bludau, J.............................................465
Bönsch, A. ..........................................417
Borchers, A. ...............................115, 449
Bormuth, M. ......................................1136
Bös, M. ................................................421
Braun, M. ............................................125
Brück, W. ............................................572
Bruenahl, C.A. ....................................553
Buchheim, A. ...........................291, 1130
Bühler, K.E. ........................................301
Busch, E..............................................285
Büttner, A.................................699, 1018
Bux, C.J. .............................................150
Calliess, I.T.........................................487
Ceballos -Baumann, A. 903, 1073, 1101
Cichy, R.M. .......................................1148
Conca, A. ............................................492
Connemann, B.J................................150
Cording, C.................................603, 609
Davids, E. ...........................................281
Deuschl, G.................................239, 251
Di Pauli, J............................................492
Diener, H.-C. .................... 180, 186, 285
Dieterich, M. .......................................769
Dietrich, W.................................747, 759
Dodel, R.......... 239, 256, 260, 269, 277
Döderlein , L.......................................396
Dommes, P.........................................285
Donix, M..............................................477
Dörr, J.........................................560, 587
Dorst, J................................................362
Dvorak, F. ...........................................352
Eckermann, G.................................... 969
Eger, K................................................ 595
Eggert, K..........239, 241, 246, 269, 277
Eitel, I. ................................................. 301
Elger, C.E.....................................61, 969
Engelhardt, A. .................................... 567
Erbguth, F.................................. 747, 759
Esselmann, H........................... 853, 861
Evers, S. .....................3, 13, 27, 32, 186
Fietzek, U.M....................................... 396
Fietzek, U.M....................................... 903
Förch, C.............................................. 352
Franke, S.........239, 241, 246, 251, 269
Fritzen, S............................................ 368
Fuhr, U................................................ 969
Galert, T.............................................. 618
Gallinat, J. .......................................... 381
Gasser, T............................................ 239
Gebhardt, R.-P. ................................. 173
Gendolla, A. ..........................................32
Gerhard, H......................................... 285
Gold, R................................................ 572
Lampl, C............................................. 186
Lang, M. .............................................. 173
Lesch, K.P.......................................... 368
Lewczuk, P................................ 853, 861
Liepelt, I. ............................................. 277
Linden, M. ........................................... 553
Ludolph, A.C............................. 333, 362
Luef, G. ............................................... 969
Machleidt, W. ..................................... 487
Maier, W. ...........................377, 641, 876
Maler, M. .................................... 853, 861
Marziniak, M. .........................................35
Maschke, M. ....................................... 285
May, A...........................................13, 186
Menne, J...........................................1111
Meyer, B. ..........................................1123
Meyer-Lindenberg, A. ....................... 882
Nickel, M............................................. 459
Niederberger, U....................................43
Nikkhah, G. ...........................................13
Nitsch, C............................................. 285
Oertel, H. .................229, 239, 241, 269
Haag, G. ............................................. 186
Haltenhof, H....................................... 487
Hausmann, A. .................................... 492
Heinz, A. ............................................. 381
Hermann, W....................................... 774
Hermle, L............................................ 417
Herpertz, S.C...................................1013
Heuser, I............................................. 663
Hinterhuber, H................................... 492
Hohl-Radke, F. .....................................67
Hufnagel, A. ....................................... 915
Hüll, M. ................................................ 651
Hünnerkopf, R................................... 891
Hurst, M. ............................................. 781
Isermann, H....................................... 407
Jansen, S. .......................................... 685
Jennen-Steinmetz, C........................ 411
Jessen, F............................................ 659
Juckel, G............................................. 381
Jüttler, E. ............................................ 343
Kaduszkiewicz, H.............................. 670
Kanis, T............................................... 277
Katsarava, Z....................................... 186
Keidel, M. ............................................ 156
Klafki, H.-W. .............................. 853, 861
Klapp, B.F........................................... 553
Klein, H.E. ................................. 603, 609
Klockgether, T. .................................. 239
Kolb, A. .............................................1130
Konradt, B. ......................................... 790
Kornhuber, J. ............................ 853, 861
Kropp, P........................................43, 186
Kuehnlein, P....................................... 362
Kühn, K.-U.......................................... 690
Külz, S................................................. 679
Kumbier, E. ......................................1013
http://www.nervenheilkunde-online.de
Pantel, J.................................................49
Paulig, M. ..........................................1095
Paulus, W..............................................22
Pedrosa Gil, F.................................... 459
Peter, A.............................................1130
Petermann, F..................................... 805
Pfaffenrath, V..................................... 180
Pohlmann-Eden, B...............................61
Potschka, H........................................ 993
Rácz, I................................................. 897
Reese, J.-P. ....................................... 260
Reichmann, H.................................... 239
Reif, A. ................................................ 368
Reiners, K........................................... 763
Reuster, T........................................... 477
Rienhoff, O. ........................................ 679
Ringel, F. ..........................................1123
Rogozinski, A. .................................... 285
Rosenbohm, A. .................................. 150
Rothoerl, R.D...................................1123
Ruchsow, M. ...................................... 417
Rühle, K.H........................................1018
XX
Autoren – Nervenheilkunde 2007; 26 (1-12)
Sándor, P.S........................................186
Schlagenhauf, F. ...............................381
Schläpfer, T........................................923
Schleim, S.
......... 83, 312, 505, 618, 813, 1041
Schmid-Elsaesser, R......................1115
Schmidt, D.......................... 61, 953, 969
Schmidt, M.H......................................411
Schmidtke, K......................................651
Schmitt, A. ..........................................368
Schneider, F.......................................277
Schoepf, D..........................................790
Schoser, B.G.H.................................... 74
Schröder, J........................................... 49
Schroeteler, F.. ..................................903
Schulte-Herbrüggen, O. ...................663
Schulze, U........................................1130
Schulze-Bonhage, A. ......................1006
Schürmann, B. ...................................897
Schütz, C.G. .......................................465
Schwaninger, M. ................................357
Sellhaus, B. ........................................763
Sitzer, M..............................................352
Sommer, C.........................................763
Soyka, D. .......................... 113, 541, 737
Sperfeld, A.D......................................362
Spießl, A. ...................................603, 609
Spießl, H....................................603, 609
Spitzer, M. ....9, 79, 119, 200, 233, 309,
337, 424, 453, 501, 545, 615, 645,
710, 743, 810, 847, 920, 957,
1036, 1079, 1144
Spottke, A. .................................256, 277
Spranger, T. ............................813, 1041
Staedt, J................................................ 67
Stefan, H...................................... 61, 965
Steiner, T. ...........................................343
Steinhoff, B.J......................................969
Stephan, M. ........................................595
Straube, A..................................186, 774
Wagner-Sonntag, E........................1083
Walbert, T........................................... 260
Walter, H.
......1, 83, 312, 505, 790, 813, 841,
1041
Weiler, H.N......................................... 387
Weimar, C.......................................... 285
Westheide, J...................................... 690
Wiedenhöfer, B.................................. 396
Wiese, B. ............................................ 670
Wiltfang, J.................................. 853, 861
Winkel, S. ........................................... 805
Wolf, R.C............................................ 134
Wörz, R............................................... 167
Wrase, J. ............................................ 381
Wüllner, U.................................. 239, 246
Ziegenbein, M. ................................... 487
Ziegenhain, U..................................1130
Ziegler, K................................. 903, 1088
Zimmer, A. .......................................... 897
Zink, M. .................................... 882, 1029
Zipp, F........................................ 560, 587
Täschner, K.-L. ..................................481
Tenfelde, V. ........................................285
Thome, J.............................................891
Trenkwalder, C..................................239
Trinka, E..............................................981
Üçeyler, N...........................................763
Unger, J. .............................................357
Urbach, H..........................................1041
van den Bussche, H..........................670
van Schayck, R.H..............................781
Vasic, N......................................134, 141
Vesper, J............................................... 13
Vicari, A. ............................................1130
von Wietersheim, H.........................1130
http://www.nervenheilkunde-online.de
XXI